Cheetah Medical has announced it has raised $9 million in financing. 

Cheetah Medical, based in Newton Center, Mass., is a developer of non-invasive hemodynamic monitoring, including the CHEETAH NICOM hemodynamic management system.

Leading the investment round was Fletcher Spaght Ventures, a Boston-based balanced-stage venture capital firm investing in healthcare/life sciences and related information technology companies.

Also participating in the financing round were Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures.